[1] 樊立. 氨氯地平联合缬沙坦治疗老年2型糖尿病肾病合并高血压的临床效果观察[J].中国医疗设备,2017,32(51):45. [2] 邱炽昌. 氨氯地平联合缬沙坦治疗老年2型糖尿病肾病合并高血压的可行性分析[J].中外医疗,2018,37(13):99-100,103. [3] 刘晓晖.缬沙坦联合氨氯地平在2型糖尿病肾病合并高血压患者治疗中的价值[J].中国社区医师,2018,34(21):35,37. [4] WANG JG,Yukisada K,Sibulo A Jr,et al.Efficacy and safety of sacubitril/valsartan (LCZ696) add-on to amlodipine in Asian patients with systolic hypertension uncontrolledwith amlodipine monotherapy[J].Journal of hypertension,2017,35(4):877-885. [5] 黄显元,刘建红,朱彦儒.α-硫辛酸对糖尿病肾病自噬相关因子LC3、Rab7和Beclin1表达的影响[J].中国免疫学杂志,2019,35(17): 2073-2078. [6] 李久胜,武静.前列地尔联合硫辛酸治疗老年糖尿病肾病临床疗效及其对血清炎症因子的影响[J].中国处方药,2020,18(2):65-66. [7] 郭玉强,袁玉飞,徐亚光,等.α-硫辛酸辅助治疗对糖尿病肾病患者肾功能及血清hs-CRP、TNF-α水平的影响[J].中国实用医刊,2020, 47(3):94-97. [8] M. K. Ranganath,Prasanta Deka,Kalyani Arikatla.Simultaneous method development and Validation of Amlodipine and Valsartan by HPLC[J].Research journal of science and technology,2020,12(3):183-189. [9] 莫志宁,何卫平,刘央.硫辛酸结合前列地尔对早期糖尿病肾病患者尿微量蛋白及胱抑素C含量的影响[J].海峡药学,2020,32(5):122-123. [10] 张琳娟.缬沙坦联合硫辛酸对早期糖尿病肾病的疗效及安全性分析[J].中外女性健康研究,2020(12):21,27. [11] Smajić,Miralem,Vujić,et al.Application of central composite design and structural analysis to the optimization of HPLC method for simultaneous analysis of hydrochlorothiazide, amlodipine besylate and valsartan[J].Main group chemistry,2018,17(2):165-180. [12] 李劲鸿,王红.缬沙坦氨氯地平片联合α-硫辛酸治疗老年2型糖尿病肾病合并高血压的效果及安全性[J].昆明医科大学学报,2021,42(4):53-56. |